Regular and Sustained Performance Revenue(in €m) (1) 21 000 +6.0% EPS (in €) +7.5% 18 000 CAGR(2) 5,0 CAGR(2) 15 000 over 30 years over 30 years 4,0 12 000 3,0 9 000 6 000 2,0 3 000 1,0 0 0,0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 (1) Cashflow(in €m) +6.9% 3,0 Dividend (in € per share) +8.6% 4 500 4 000 CAGR(2) 2,5 CAGR(2) 3 500 over 30 years over 30 years 3 000 2,0 2 500 1,5 2 000 1 500 1,0 1 000 0,5 500 0 0,0 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 (1) Adjusted for the 2-for-1 share split in 2007, for attributions of free shares and for a factor of 0.974 reflecting the value of the rights of the capital increase completed in October 2016. (2) Calculated according to prevailing accounting rules over 30 years. 50 15 February 2018 Full Year 2017 Results The world leader in gases, technologies and services for Industry and Health